Perrigo Company (Nasdaq: PRGO) today announced that it has acquired rights to Novel Laboratories' pending ANDA for HalfLytely and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE